Mefenamic Acid: Comprehensive Guide to Indications, Dosage, and Cardiac and Gastrointestinal Risks
Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) used to relieve mild to moderate pain, particularly menstrual pain, but it carries important warnings regarding cardiac and gastrointestinal health.
Quick Facts
Definition and Primary Uses
Mefenamic Acid is a drug belonging to the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) group, possessing effective properties in pain relief, fever reduction, and inflammation. It is considered one of the active ingredients in common drugs like Mafibin and Ponstan, and is available in the form of tablets or oral suspensions.
- Treatment of Menstrual Pain: The most common use is for relieving menstrual pain (dysmenorrhea), and the duration of use should not exceed seven days.
- Pain Relief: Used to relieve mild to moderate pain, including dental pain.
- Adjunctive Treatment: May be used to relieve inflammatory symptoms accompanying painful ear, nose, and throat infections (such as tonsillitis), but this must accompany primary treatment for the cause (viral or bacterial).
Important Note: Mefenamic Acid is not used to treat fever alone; it must be accompanied by clear inflammatory symptoms such as pain or swelling.
Suggested Dosages and Duration of Use
The usual recommended dose is an initial dose of 500 mg, followed by 250 mg every 6 hours as needed, and the duration of treatment should not exceed 7 consecutive days. This regimen is suitable for adults aged 14 years and older.
- For Menstrual Pain: Start the first dose with the onset of bleeding and continue treatment for the duration of the period, maximum 7 days.
- Elderly and Kidney Impairment: Must adhere to the lowest possible dose and the shortest possible duration, and its use is absolutely prohibited in cases of clear kidney function impairment.
The dose should not be adjusted or stopped without consulting a doctor, and this applies particularly to the elderly or those with impaired liver function where sensitivity is greater.
Major Cardiac and Gastrointestinal Risks and Warning
All non-steroidal anti-inflammatory drugs, including Mefenamic Acid, carry an increased risk of serious cardiovascular events (such as heart attacks and strokes), and this risk increases with the duration of treatment and increased doses.
- Gastrointestinal Risks: The drug increases the risk of bleeding ulcers and perforation of the stomach and intestines, conditions that may occur without warning, especially in the elderly.
- Symptoms of Gastrointestinal Bleeding: Require immediate discontinuation of the drug if bloody vomit, bloody diarrhea, or black, sticky stools appear.
- At-Risk Patients: Those with previous cardiovascular disease, high blood pressure, diabetes, or smokers must use it at the lowest dose and for the shortest duration.
The risk of gastrointestinal bleeding significantly increases when Mefenamic Acid is taken concurrently with blood thinning medications, corticosteroids, or SSRI antidepressants.
Contraindications and Special Precautions
Mefenamic Acid must be strictly avoided in specific medical conditions, most importantly the advanced stages of pregnancy and cases of renal failure or active gastrointestinal problems.
- Contraindications: Do not use if you have a known allergy to the substance, after recent heart surgery, or in the last three months of pregnancy.
- Pregnancy (First and Second Trimesters): Given only for absolute necessity and at the lowest possible dose, due to the risks of fetal cardiopulmonary toxicity.
- Breastfeeding: Can be used with extreme caution and at the lowest effective dose, but safer alternatives for the infant are available, especially if newborn or premature.
- Kidneys and Liver: Use is prohibited in cases of renal function impairment, and used with great caution in cases of hepatic function disorder.
Taking Mefenamic Acid in the last three months of pregnancy leads to serious risks for the fetus, such as premature closure of the ductus arteriosus and delayed delivery due to inhibition of uterine contractions.
Frequently Asked Questions (FAQs)
Can I use Mefenamic Acid for chronic pain such as arthritis?
No, Mefenamic Acid or any other NSAID is not recommended for long periods to treat chronic pain, and the main reason is the cardiovascular and gastrointestinal risks that increase with the duration of use. The maximum recommended duration for intermittent use is 7 days.
To manage chronic pain, consult a doctor to prescribe other pain relievers or anti-inflammatory treatments with a better safety profile for long-term use, or to combine Mefenamic Acid with stomach-protecting drugs.
Why does Mefenamic Acid pose a risk to the heart in patients with hypertension and diabetes?
Since Mefenamic Acid inhibits prostaglandin production, it can lead to sodium and fluid retention and raise blood pressure, as well as increase the risk of blood clot formation (vascular effect). Patients who already have risk factors such as high blood pressure or diabetes are more susceptible to myocardial infarction or stroke as a result of these effects.
Therefore, its use is emphasized to be limited to the lowest effective dose and for the shortest possible duration, especially for these at-risk categories.
What are the signs indicating gastrointestinal bleeding while taking the drug?
The most dangerous symptoms of gastrointestinal bleeding that require immediate attention are: vomit resembling coffee grounds (indicating older bleeding), or frank red bloody vomit, bloody diarrhea, or black and sticky stools (indicating upper gastrointestinal bleeding). These symptoms require stopping the drug and going to the emergency room.
These symptoms can occur without warning, even if you have no previous stomach history, so any change in the color or nature of digestive secretions must not be ignored.
Is there a relationship between Mefenamic Acid and SSRI antidepressants?
Yes, there is an interaction that increases risks. Selective Serotonin Reuptake Inhibitors (SSRIs) naturally increase the risk of gastrointestinal bleeding. When taken with Mefenamic Acid (which also increases the risk of bleeding), the synergy between them significantly raises the probability of dangerous gastrointestinal bleeding.
Patients taking drugs like Prozac or Lustral must consult a doctor before using Mefenamic Acid, even for a short period, to adjust the treatment plan or provide stomach protection.
What are the risks of using Mefenamic Acid in the third trimester of pregnancy?
Mefenamic Acid and any other NSAID are strictly prohibited during the last three months of pregnancy. This prohibition is due to life-threatening risks to the fetus, most notably the premature closure of the ductus arteriosus (a blood vessel that must remain open until birth), causing dangerous pulmonary hypertension in the fetus (cardiopulmonary toxicity) and may lead to renal failure.
It can also lead to prolonged bleeding time during delivery and inhibition of uterine contractions, delaying or prolonging labor.
Do Mefenamic Acid suspensions (syrup) have the same risks as tablets?
Yes, the basic risks related to Mefenamic Acid—such as cardiovascular and gastrointestinal risks—are associated with the active substance itself (Mefenamic Acid) and not the pharmaceutical form (tablet or syrup). Therefore, suspensions like Inflamil or Monstan carry the same serious warnings regarding gastrointestinal bleeding and heart clots.
The only difference is the ease of using the syrup for people who have difficulty swallowing tablets, or when prescribed for children (although its use in children must be very limited).
Do corticosteroid drugs increase the risk of stomach ulcers when taken with Mefenamic Acid?
Yes, using corticosteroids (such as Prednisolone or Betazone) with Mefenamic Acid significantly increases the probability of ulcers and bleeding in the gastrointestinal tract. Both drug groups weaken the protective layer of the stomach and intestines, and when combined, the risk multiplies, and serious side effects may occur more quickly.
Patients taking corticosteroids regularly must specifically consult a doctor before using any NSAID painkiller like Mefenamic Acid, and the doctor may prescribe a stomach-protecting drug in this case.
What signs require stopping treatment and consulting a doctor immediately?
Any appearance of cardiovascular symptoms (severe chest pain, unexplained shortness of breath), any evidence of gastrointestinal bleeding (black or bloody stool), or signs of renal failure (severe ankle swelling and unexplained weight gain), should prompt you to stop the drug immediately and consult a doctor or emergency services to avoid serious complications.
Immediate discontinuation is necessary because even if the drug is effective in relieving pain, the potential risks outweigh the benefit if these warning signs appear.
Does Mefenamic Acid interact with blood thinners like Warfarin or Aspirin?
Yes, the interaction is very serious. Patients taking anticoagulants (such as Warfarin, or even low-dose Aspirin for the heart) are significantly more susceptible to severe gastrointestinal bleeding when taking Mefenamic Acid. This interaction results from the acid inhibiting platelet function and irritating the stomach wall simultaneously.
This drug concurrency must be avoided entirely unless the doctor specifically determines that the benefit outweighs the severe risk of bleeding, with comprehensive and intensive monitoring of blood clotting parameters.
Can I use Mefenamic Acid to relieve menstrual pain for many years?
No, it should not be used for menstrual pain chronically or repeatedly. Guidelines are clear that use should not exceed 7 consecutive days. Cardiovascular side effects and gastrointestinal bleeding increase significantly with prolonged use, even at low doses.
If menstrual pain is severe and requires recurrent treatment, consult a gynecologist to determine safer therapeutic alternatives for monthly use, such as hormonal therapy or painkillers with lower gastrointestinal risks.
Disclaimer and Information Sources
- Purpose of Content: The information contained in this guide is for awareness and knowledge purposes only and is not a substitute for specialized medical consultation. Do not use this drug or any other drug without consulting your doctor or pharmacist.
- Information Source: This content was prepared relying on official, documented medical sources appropriate to the subject (such as official drug leaflets, Ministry of Health guidelines, Food and Drug Administration directives, or specialized medical organizations).
- Date of Publication | Last Updated: [October 2025]
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.